← Back to Search

Provider supervision/ feedback for Peripheral Arterial Disease (ROMEPAD Trial)

N/A
Waitlist Available
Led By Subhash Banerjee, MD, MBA
Research Sponsored by Dallas VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This trial will compare two groups of people with peripheral arterial disease - those who do home exercise with a digital monitoring system and provider supervision, and those who just use the monitoring system.

Eligible Conditions
  • Peripheral Arterial Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 6 minute walk test distance between groups
Secondary study objectives
Change in VascuQOL-6 (VQ6) quality of life survey
Change in Walking Impairment Questionnaire score

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Provider SupervisedExperimental Treatment1 Intervention
Digital monitoring system with provider supervision
Group II: Self SupervisedActive Control1 Intervention
Digital monitoring system without provider supervision

Find a Location

Who is running the clinical trial?

Dallas VA Medical CenterLead Sponsor
34 Previous Clinical Trials
4,780 Total Patients Enrolled
1 Trials studying Peripheral Arterial Disease
12 Patients Enrolled for Peripheral Arterial Disease
Subhash Banerjee, MD, MBAPrincipal InvestigatorDallas VA Hospital
~15 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top